MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
52.17
+0.29 (0.56%)
Dec 20, 2024, 4:00 PM EST - Market closed

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $3.29 billion. The enterprise value is $2.80 billion.

Market Cap 3.29B
Enterprise Value 2.80B

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

MLTX has 63.06 million shares outstanding. The number of shares has increased by 40.83% in one year.

Current Share Class 63.06M
Shares Outstanding 63.06M
Shares Change (YoY) +40.83%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 10.57%
Owned by Institutions (%) 52.11%
Float 28.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 6.74
P/TBV Ratio 6.74
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 25.51, with a Debt / Equity ratio of 0.01.

Current Ratio 25.51
Quick Ratio 24.72
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -16.80% and return on invested capital (ROIC) is -13.72%.

Return on Equity (ROE) -16.80%
Return on Assets (ROA) -13.32%
Return on Capital (ROIC) -13.72%
Revenue Per Employee n/a
Profits Per Employee -$1.62M
Employee Count 50
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $285,367 in taxes.

Income Tax 285,367
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -12.64% in the last 52 weeks. The beta is 1.30, so MLTX's price volatility has been higher than the market average.

Beta (5Y) 1.30
52-Week Price Change -12.64%
50-Day Moving Average 50.78
200-Day Moving Average 46.72
Relative Strength Index (RSI) 49.27
Average Volume (20 Days) 190,189

Short Selling Information

The latest short interest is 8.00 million, so 12.68% of the outstanding shares have been sold short.

Short Interest 8.00M
Short Previous Month 8.00M
Short % of Shares Out 12.68%
Short % of Float 28.35%
Short Ratio (days to cover) 34.43

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -108.54M
Pretax Income -58.02M
Net Income -80.77M
EBITDA -108.45M
EBIT -108.54M
Earnings Per Share (EPS) -$1.30
Full Income Statement

Balance Sheet

The company has $493.92 million in cash and $3.38 million in debt, giving a net cash position of $490.54 million or $7.78 per share.

Cash & Cash Equivalents 493.92M
Total Debt 3.38M
Net Cash 490.54M
Net Cash Per Share $7.78
Equity (Book Value) 495.50M
Book Value Per Share 7.74
Working Capital 492.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$80.46 million and capital expenditures -$628,587, giving a free cash flow of -$81.09 million.

Operating Cash Flow -80.46M
Capital Expenditures -628,587
Free Cash Flow -81.09M
FCF Per Share -$1.29
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -40.83%
Shareholder Yield -40.83%
Earnings Yield -2.45%
FCF Yield -2.46%
Dividend Details

Analyst Forecast

The average price target for MLTX is $78.33, which is 50.14% higher than the current price. The consensus rating is "Buy".

Price Target $78.33
Price Target Difference 50.14%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1